|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 658.44 EGP | +0.32% |
|
-0.69% | +88.56% |
| 06-10 | MINAPHARM Pharmaceuticals Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 05-05 | Minapharm pharmaceuticals FY standalone net profit EGP 57.5 million | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Generic Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 158M | - | - | - | - | - |
| 47.1B | |||||
| 34.57B | |||||
| 12.38B | |||||
| 11.64B | |||||
| 8.87B |
Select your edition
All financial news and data tailored to specific country editions
